Mazdutide Real Results: Weight Loss Timeline & What Patients Report
The GLORY-1 phase 3 trial provides the most reliable data on what to expect from mazdutide.
Mazdutide How It Works: Mechanism of Action Explained
Mazdutide is the first dual GLP-1 and glucagon receptor agonist approved for obesity.
Mazdutide Latest Research: New Indications, Trials & What’s Coming
Mazdutide has the most active research pipeline of any drug in the GLP-1/glucagon dual agonist class.
Mazdutide Who Should (and Shouldn’t) Take It: Eligibility & Contraindications
Mazdutide is approved in China for adults with a BMI of 28 or higher, or BMI of 24 or higher with at least one weight-related comorbidity.
Mazdutide Drug Interactions: What You Can and Can’t Take with It
Mazdutide doesn’t have a long list of dangerous drug interactions, but a few categories matter.
Mazdutide Dosing Guide: Schedule, Titration & What to Expect Each Week
Mazdutide uses a four-step titration over 12 to 16 weeks before patients reach a maintenance dose.
Mazdutide Cost Breakdown: Brand, Compounded, Insurance & Savings Options
Mazdutide pricing exists only in China today, where Innovent launched it under the brand name Xinerjia in mid-2025.
Managing Nausea on GLP-1: Diet Tricks That Actually Help
Nausea is the most common side effect on GLP-1 medications, full stop. In the STEP 1 trial (Wilding et al.
Maintenance After GLP-1: Building Habits That Last
The hard truth about weight maintenance after GLP-1 medications: most people don’t maintain. STEP 4 (Rubino et al.
